Procarbazine in Treating Patients With Recurrent Brain Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart A. Grossman, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 1999
- Primary completion
- —
- Completion
- 31 Aug 2003
- Last update posted
- 21 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00004004
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.